Effect of atrial fibrosis on clot burden score and physicochemical properties of thrombus in patients with ischaemic stroke occurring in non-valvular atrial fibrillation

Effect of atrial fibrosis on clot burden score and physicochemical properties of thrombus in patients with ischaemic stroke occurring in non-valvular atrial fibrillation

Background To investigate the effect of the degree of atrial fibrosis on the clot burden score (CBS) and physicochemical properties in patients with acute ischaemic stroke (AIS) due to non-valvular atrial fibrillation (NVAF). Methods A total of 117 patients with AIS in NVAF attending the Department...

Full description

Saved in:

Bibliographic Details
Main Authors:	Juan Zhao, Guangjun Deng, Weijing Wang, Peng Wang, Xinyu Shen, Xiaoxiao Yuan, Haifei Jiang, Zhong-bao Ruan
Format:	Article
Language:	English
Published:	PeerJ Inc. 2025-03-01
Series:	PeerJ
Subjects:	Atrial fibrosis Atrial fibrillation Acute ischemic stroke Clot burden score Thrombus
Online Access:	https://peerj.com/articles/19173.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Predictors of Thrombus Dissolution in the Left Atrial Appendage in Patients with Persistent Nonvalvular Atrial Fibrillation
by: E. S. Mazur, et al.
Published: (2022-03-01)

Associations of the left atrial epicardial fat thickness with the thrombosis prevalence and left atrial appendage flow velocity in patients with persistent non-valvular atrial fibrillation
by: E. S. Mazur, et al.
Published: (2024-05-01)

GORE® CARDIOFORM ASD occluder thrombus in a patient of rheumatoid arthritis occurred three days after deployment
by: Naomi Nakagawa, et al.
Published: (2025-09-01)

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?
by: I. A. Zaigraev, et al.
Published: (2023-05-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
by: I. S. Yavelov
Published: (2025-08-01)

Glutathione peroxidase 4 as a potential biomarker for atrial fibrosis and recurrence of atrial fibrillation
by: Tong Liu, MD, et al.
Published: (2025-05-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Risk factors of incomplete endothelialization after left atrial appendage occlusion in patients with atrial fibrillation
by: Jia-Min Chen, et al.
Published: (2024-06-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Patients with metabolic syndrome and premature atrial contractions: predicting the atrial fbrillation onset
by: A. I. Olesin, et al.
Published: (2022-06-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: S. V. Nedogoda, et al.
Published: (2017-03-01)

Role of miRNA in the development of atrial fibrillation in patients with valvular heart disease
by: I. V. Abdulyanov, et al.
Published: (2020-11-01)

PROTEOLYTIC ACTIVITY OF MILK-CLOTTING ENZYMES OF DIFFERENT ORIGIN
by: D. S. Myagkonosov, et al.
Published: (2022-03-01)

Thrombus composition and distribution patterns by thrombus volume in acute ischemic stroke
by: Jaeseob Yun, et al.
Published: (2025-08-01)

Risk Factors Associated with Cardioembolic Stroke in Patients with non Valvular Atrial Fibrillation
by: Daniel Guerra García, et al.
Published: (2018-02-01)

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01)

Additional diagnostic criteria for atrial cardiomyopathy in patients with lone atrial fibrillation
by: E. A. Polyanskaya, et al.
Published: (2021-02-01)

ENDOVASCULAR METHODS FOR CLOSURE OF THE LEFT ATRIAL APPENDAGE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION FOR STROKE PREVENTION
by: R. V. Guchaev, et al.
Published: (2018-05-01)

Relief of persistent atypical atrial flutter: experience with the use of niferidil
by: E. A. Zakharyan, et al.
Published: (2023-03-01)

Commentary on “Cryoablation of pulmonary veins in a patient with an atrial septal occluder and atrial fibrillation: A case report”
by: Randa Tabbah
Published: (2025-06-01)

The Dynamic Relationship Among Atrial Pacing, Premature Atrial Beats, Mode Switching, and Atrial High-Rate Episodes in Patients with Sick Sinus Syndrome
by: Barış Yaylak, et al.
Published: (2025-03-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

EXAMINATION OF ELECTROPHYSIOLOGICAL PARAMETERS OF THE ATRIUMS IN PATIENTS WITH LONG-TERM PERSISTENT FORM OF ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE
by: A. A. Kulikov, et al.
Published: (2017-12-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
by: Jean Michell Correia Monteiro, et al.

Left Atrial Strain—Current Review of Clinical Applications
by: Constantin Andrei Rusali, et al.
Published: (2025-05-01)

Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions
by: V. A. Ionin, et al.
Published: (2021-05-01)

Analysis of soluble thrombomodulin contents in blood serum of patients with non-valvular atrial fibrillation: gender dependence
by: O. N. Ogurkova, et al.
Published: (2025-01-01)

Clinical case of using manual thrombus aspiration during percutaneous coronary intervention in a patient with ST-segment elevation myocardial infarction type 2
by: V. M. Mironov, et al.
Published: (2016-02-01)

Histopathological composition of thrombus material in a large cohort of patients with acute ischemic stroke: a study of atypical clots
by: Laura Rojas-Bartolomé, et al.
Published: (2025-03-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

Cisd2 delays atrial aging via a modulation of calcium homeostasis that mitigates atrial myopathy
by: Chi-Hsiao Yeh, et al.
Published: (2025-08-01)

Safety and effectiveness of Rivaroxaban, Dabigatran and Apixaban in patients with non-valvular atrial fibrillation for stroke prophylaxis
by: Ceyda Tanoğlu, et al.
Published: (2025-07-01)

Right atrium thrombus in the presence of an atrial septal defect: a case report
by: S. A. Chepurnenko, et al.
Published: (2023-10-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
by: E. V. Kokhan, et al.
Published: (2021-07-01)